Announcements Trials

Browse Landscape

Phase

Status

Completed 10 Unknown 3 Recruiting 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Anxiety Disorders 2 Trauma, Nervous System 1 Terminal Illness 1 Subarachnoid Hemorrhage 1 Stroke 1 Spinal Cord Injuries 1 Smoking Cessation 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Neoplasms 1 Meningitis 1 Fallopian Tube Neoplasms 1 Encephalitis 1 Carcinoma, Ovarian Epithelial 1 Brain Neoplasms 1 Brain Injuries, Traumatic 1 Brain Injuries 1 Autoimmune Diseases 1

Interventions

Blood Specimen Collection 38 pembrolizumab 36 Bevacizumab 22 Surveys and Questionnaires 18 Standard of Care 18 Radiotherapy 18 Exercise 17 Carboplatin 16 Nivolumab 15 atezolizumab 14 Cisplatin 14 Drug Therapy 13 Paclitaxel 12 Fluorouracil 12 Cyclophosphamide 12 Cetuximab 12 Trastuzumab 10 Leucovorin 10 Docetaxel 10 Dexamethasone 10 Pemetrexed 9 Oxaliplatin 9 Biopsy 9 pertuzumab 8 olaparib 8 Temozolomide 8 Panitumumab 8 Observation 8 Irinotecan 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Music Therapy × Clear all

NCT07198971 2026-04-09

TEMPOS

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting

Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡